$EW Income Statement | Understand Stock

$EW

$91.78 +$0.96 (1.06%) Close

$EW Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net sales
Cost of sales
Gross profit
Selling, general, and administrative expenses
Research and development expenses
Intellectual property agreement and certain litigation expenses (Note 3)
Change in fair value of contingent consideration liabilities (Note 13)
Special charge and separation costs (Note 4)
Restructuring charges, separation costs, and other (Note 4)
Intangible assets impairment charges
Other operating income
Operating income
Interest expense
Interest income
Loss on impairment
Other non-operating income, net (Note 18)
Income from continuing operations before provision for income taxes
Provision for income taxes (Note 19)
Net income from continuing operations
Income from discontinued operations, net of tax
Net income
Less: Net loss attributable to noncontrolling interest
Net income attributable to Edwards Lifesciences Corporation.
Share information (Note 2):
Earnings per share attributable to Edwards Lifesciences Corporation:
Basic
Continuing operations (in dollars per share)
Discontinued operations (in dollars per share)
Basic earnings per share (in dollars per share)
Diluted:
Continuing operations (in dollars per share)
Discontinued operations (in dollars per share)
Diluted earnings per share (in dollars per share)
Weighted-average number of common shares outstanding attributable to Edwards Lifesciences Corporation:
Basic (in shares)
Diluted (in shares)

Comments